For an adult with occasional constipation, how do Dulcolax (bisacodyl) and Senna (sennosides) compare regarding efficacy, dosing, onset of action, and safety?

Dulcolax vs Senna for Occasional Constipation

For occasional constipation in adults, both Dulcolax (bisacodyl) and senna are effective stimulant laxatives recommended for short-term or rescue therapy, but bisacodyl has a faster onset (6-12 hours oral, 30-60 minutes suppository) compared to senna (6-12 hours), though bisacodyl causes significantly more side effects at standard doses (53.4% diarrhea, 24.7% abdominal pain) versus senna's lower side effect profile. 1

Key Comparative Points

Efficacy

Both agents are effective stimulant laxatives with similar mechanisms of action:

• Bisacodyl: Moderate certainty of evidence for efficacy in chronic constipation 1
• Senna: Low certainty of evidence (based on only one small RCT), but showed impressive results with 7.6 more bowel movements per week versus placebo 1

The 2023 AGA-ACG guidelines conditionally recommend both agents, noting they work through similar pathways—stimulating colonic peristalsis and secretion 1.

Dosing Recommendations

Bisacodyl:

• Start with 5 mg orally (not the 10 mg studied in trials, which caused excessive side effects) 1
• Maximum: 10 mg daily 1
• Suppository form: 10 mg rectally 1

Senna:

• Start with 8.6-17.2 mg daily (one to two tablets of 8-9 mg each) 1
• The 1 g dose used in trials is higher than typical clinical practice; 83% of trial participants reduced their dose 1
• Maximum: 4 tablets twice daily 1

Onset of Action

Bisacodyl has more flexibility:

• Oral tablet: 6-12 hours 1
• Rectal suppository: 30-60 minutes (fastest option for rapid relief) 1

Senna:

• 6-12 hours 2

Safety Profile - Critical Difference

Bisacodyl at 10 mg has substantially higher side effect rates:

• Diarrhea: 53.4% vs 1.7% placebo 1
• Abdominal pain: 24.7% vs 2.5% placebo 1
• Most adverse events occur in the first week 1

Senna at 10 mg shows better tolerability:

• Diarrhea: 31.8% vs 4.5% placebo 1
• Abdominal pain: 5.6% vs 2.2% placebo 1
• No severe treatment-related adverse events reported in trials 1

A 2019 ICU study found fewer complications with senna compared to bisacodyl on day 3 of treatment 3.

Cost and Availability

Both are inexpensive (<$50/month) and available over-the-counter 1

Clinical Decision Algorithm

Choose Bisacodyl suppository when:

• Rapid relief needed (30-60 minutes onset)
• Patient can tolerate rectal administration

Choose Bisacodyl oral (5 mg starting dose) when:

• Standard overnight relief acceptable
• Patient prefers oral medication
• Willing to accept higher risk of cramping/diarrhea

Choose Senna (8.6-17.2 mg starting dose) when:

• Standard overnight relief acceptable
• Patient has history of sensitivity to laxatives
• Lower side effect profile is priority
• Cost and OTC availability are important 1

Important Caveats

Both agents are contraindicated in:

• Ileus or intestinal obstruction
• Severe dehydration
• Acute inflammatory bowel conditions 1

Critical Limitations:

• Both recommended for short-term or rescue therapy only—long-term effectiveness has not been studied 1
• Antibiotic use may decrease efficacy of both agents (they require gut bacteria for activation) 1
• Senna not recommended in pregnancy due to potential weak genotoxic effects in animals 1
• Start at lower doses than studied in trials to minimize side effects 1

Common Pitfall to Avoid:

Do not start with the 10 mg doses used in clinical trials—these caused unacceptably high rates of diarrhea and abdominal pain. Begin with 5 mg bisacodyl or 8.6-17.2 mg senna and titrate up only if needed 1.

The evidence suggests senna may be preferable for most patients with occasional constipation due to its better tolerability profile, though bisacodyl suppositories remain the fastest-acting option when rapid relief is essential.